Result of AGM

Probiotix Health PLC
26 July 2023
 

ProBiotix Health plc

("ProBiotix" or the "Company")

 

Result of AGM

 

ProBiotix Health plc (AQSE: PBX), a life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions, announces that at the AGM held earlier today, all resolutions were duly passed.

 

The full voting results will be available on the website in due course here: https://probiotixhealth-ir.com/

 

For further information, please contact:

 

ProBiotix Health plc

https://probiotixhealth-ir.com/

Steen Andersen, Chief Executive

Contact via Walbrook below



Peterhouse Capital Ltd (AQSE Corporate Adviser and Broker)

Tel: 020 7469 0930

Mark Anwyl


Duncan Vasey


 


Walbrook PR Ltd

probiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings